JW Life Science (XKRX:234080) YoY EBITDA Growth : -14.69% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is JW Life Science YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. JW Life Science's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -14.69%.

JW Life Science's EBITDA per Share for the three months ended in Mar. 2024 was ₩778.84.

JW Life Science YoY EBITDA Growth Historical Data

The historical data trend for JW Life Science's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Life Science YoY EBITDA Growth Chart

JW Life Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

20.21

-9.74

-11.32

19.02

33.80

JW Life Science Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															43.28	5.68	12.62	37.59	-14.69

JW Life Science YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

JW Life Science's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(3354.569	-	2507.094)	/	\| 2507.094 \|
=	33.80 %

JW Life Science's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(778.841	-	912.979)	/	\| 912.979 \|
=	-14.69 %

JW Life Science YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of JW Life Science's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Life Science (XKRX:234080) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Life Science Corp (XKRX:234080) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

28, Hanjin 1-gil, Songak-eup, Dangjin-si, Chungcheongnam-do, Seoul, KOR, 343-823

Website

http://www.jw-lifescience.co.kr

JW Life Science Corp develops and produces infusion solutions. Its products contents amino acids, lipids, proteins, vitamins, and minerals to patients.

JW Life Science (XKRX:234080) Headlines

No Headlines